Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-003250
Filing Date
2025-04-08
Accepted
2025-04-08 17:01:10
Documents
83
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1780541
2 ex19-1.htm EX-19.1 66587
3 ex21-1.htm EX-21.1 3601
4 ex23-1.htm EX-23.1 3769
5 ex31-1.htm EX-31.1 16811
6 ex32-1.htm EX-32.1 8325
7 form10-k_001.jpg GRAPHIC 11994
  Complete submission text file 0001641172-25-003250.txt   7738699

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE hepa-20241231.xsd EX-101.SCH 44980
9 XBRL CALCULATION FILE hepa-20241231_cal.xml EX-101.CAL 67599
10 XBRL DEFINITION FILE hepa-20241231_def.xml EX-101.DEF 243290
11 XBRL LABEL FILE hepa-20241231_lab.xml EX-101.LAB 449969
12 XBRL PRESENTATION FILE hepa-20241231_pre.xml EX-101.PRE 389629
85 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1107597
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36856 | Film No.: 25822692
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)